Playground Global: $410 Million Raised, Bringing AUM To Over $1.2 Billion

By Amit Chowdhry • Dec 18, 2023

Playground Global recently announced that it has raised $410 million in new capital, bringing the firm’s assets under management to more than $1.2 billion. And Playground Global is an early-stage and deep-tech venture firm investing in transformative technologies and founders building category-defining businesses.

Similar to Fund II, the capital deployments in Fund III will focus on Seed and Series A companies with initial investments ranging from $1 million to $20 million across next-gen computing, logistics, automation, infrastructure, decarbonization, engineered biology, etc. Playground has already made several investments from Fund III, including d-Matrix, Ideon Technologies, Amber Bio, Infinimmune, and Atomic AI, along with other portfolio companies operating in stealth.

Since being founded, Playground has funded companies developing the foundational layers of emerging technologies. And with an exponentially growing gap between appetite for computation and what Moore’s Law can deliver, Playground backs companies defining the next generation of computing. These advancements will pave the path for innovation across all sectors.

Playground looks for founders and technologies that will establish the foundational layer of industries, old and new. In artificial intelligence, Playground invested early in the foundational layer of hardware & software. And in 2016, Playground partnered with Neuroscientist Naveen Rao to bring Nervana Systems, the first AI hardware accelerator, to market, and Intel quickly acquired the company. Ahead of the AI revolution in 2021, Playground partnered again with Naveen Rao and MosaicML, a company training and deploying large language models on the enterprise’s internal data. In June 2023, Databricks acquired Mosaic for $1.3 billion, the largest acquisition of a generative AI company.

Starting in Fund II and continuing with the new funds, Playground has refined and expanded its life sciences thesis to focus on founder-led engineered biology startups, building the future of emerging modality therapeutics development and unlocking AI/ML workflows to refactor drug development. General Partner Jory Bell and Venture Principal Benjamin Kim have led investments within this vertical, backing segment-leading companies, including Ultima Genomics, Strand Therapeutics, Manifold Bio, and Outpace Bio.

Playground Global’s team includes more than 40 people, many of whom have technical backgrounds and leverage their expertise to identify and support technology companies. And the skills of the investment and technology teams are complementary to those of the operating and platform teams, which ensures support for areas including capital formation, business development, talent, and marketing at the earliest stages.

KEY QUOTES:

“We are witnessing a great acceleration in the development of consequential technologies with entirely new classes of computing, AI, and automation, driving innovation across material science and drug discovery. In 2023 alone, we’ve seen Relativity Space launch the first 3D-printed rocket to space, Universal Hydrogen flew the world’s largest hydrogen-powered plane, and Amazon announced that it will begin testing Agility Robotic’s bipedal robot, Digit, for use in their operations. We’re thrilled to back these companies that are making an impact, today, and for generations to come.”

— Peter Barrett, co-founder and General Partner at Playground Global

“Life sciences is experiencing its industrial revolution, and Playground is investing at the nexus of next-gen compute, AI, synbio, automation and complex data generation tools to build the biotech ecosystem of the future. To date, we’ve only been able to understand biology in relatively simplistic terms. Untangling the profound complexity of life requires scaled deployment of AI, which in turn relies on generating tremendous volumes of high quality relevant biological training data. This will underpin a new era of safer, more effective medicines across a broad swath of indications.”

— Jory Bell

“Deep technology is no longer a synonym for slow technology. We are at a tipping point, witnessing companies transform major industries rapidly. We look forward to supporting founders with hands-on experience, a community of entrepreneurs and operators across business functions, and office space as they develop commercially viable products at scale.”

— Bruce Leak, co-founder and General Partner at Playground Global